Lupin receives FDA tentative approval for HIV treatment generic
07 Dec 2024 //
EXPRESSPHARMA
ViiV To Present Dovato Vs Biktarvy Trial Data At AIDS 2024
16 Jul 2024 //
INDIANPHARMAPOST
DoP directs NPPA to recalculate ceiling price of three after Cipla`s petition
03 Jun 2024 //
PHARMABIZ
ViiV Healthcare announces FDA Approval of Dovato for Adolescents Living with HIV
08 Apr 2024 //
BUSINESSWIRE
ViiV Health announces new packaging option now available in the U.S. for Dovato
05 Feb 2024 //
BUSINESSWIRE
Viatris Announces U.S. FDA Approval of a Paediatric Formulation of Abacavir
05 Sep 2023 //
PR NEWSWIRE
Laurus Labs Generic Abacavir Sulfate Receives Approval in the U.S.
25 Jul 2022 //
FDA
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
14 Jun 2022 //
EXPRESS PHARMA
Cipla`s Generic Dolutegravir, Lamivudine Receives Approval in the U.S.
28 Jan 2022 //
FDA
HebaBiz`s application for phase 3 trial in China for Clevudine has been approved
15 Nov 2021 //
PRNEWSWIRE
ViiV seeks FDA approval for dispersible single tablet regimen with dolutegravir
05 Oct 2021 //
PHARMABIZ
ViiV seeks FDA approval for dispersible single tablet regimen with dolutegravir
05 Oct 2021 //
PHARMABIZ
ViiV Healthcare presents three-year switch data for Dovato
29 Sep 2021 //
BUSINESSWIRE
The Food and Drug Administration approved revisions to the TRIUMEQ
12 Mar 2021 //
FDA
ViiV confirms 2-drug HIV regimen on par with 3-drug combo
14 Oct 2020 //
GKPREABIOMED
Dolutegravir plus lamivudine shows non-inferior HIV-1 in Ph III trials
08 Oct 2020 //
EUROPEALPHARMACEUTICAL
Inflammasome Therapeutic Says Study Reported Treatment or Prevention of Diabetes
23 Sep 2020 //
BUSINESSWIRE
ViiV reports promising data from Phase IIIb HIV study of Dovato
21 Aug 2020 //
CLINICALTRIALSARENA
ViiV Healthcare announces FDA approval of an expanded indication for Dovato
06 Aug 2020 //
BUSINESSWIRE
GSK ViiV`s Dovato triumphs in #FierceMadness DTC ad contest
05 Apr 2020 //
FIERCEPHARMA
Shandong Langnuo new drug R&D incubation pilot test and production assessment
11 Feb 2020 //
PRESS RELEASE
Warm congratulations successful passing of GMP inspection of Lonno`s Lamivudine
07 Feb 2020 //
PRESS RELEASE
Roche`s Ocrevus, GSK`s Dovato ads top November TV spending chart
19 Dec 2019 //
FIERCE PHARMA
GSK`s ViiV launches first campaign for new HIV med Dovato
10 Oct 2019 //
FIERCE PHARMA
Merck’s PIFELTRO™ and DELSTRIGO™ get FDA permission to treat HIV-1
25 Sep 2019 //
BIOSPECTRUMASIA
Merck`s Big Week: HIV Approval and Landmark 3-Country Approval for Keytruda
20 Sep 2019 //
BIOSPACE
Enforcement Report - Week of September 18, 2019
18 Sep 2019 //
FDA
FDA Action Alert: Merck and Amarin
16 Sep 2019 //
BIOSPACE
PvPI study reveals major suspected ADRs in anti-retroviral drugs
07 Aug 2019 //
PHARMABIZ
ViiV builds confidence in 2-drug HIV pill with new Dovato data
25 Jul 2019 //
FIERCE PHARMA
ViiV’s Investigational HIV Drug Finds Success in Hard-to-Treat Patient
23 Jul 2019 //
BIOSPACE
Fosun Pharma picks up GSK plant along with rights to make Epivir generic
10 Jul 2019 //
FIERCE PHARMA
GSK`s Dovato meets primary goal in late-stage HIV study
09 Jul 2019 //
REUTERS
ViiV secures EU nod for HIV therapy Dovato
02 Jul 2019 //
PHARMATIMES
FDA Plots Shift Away From CSR Pilot to Forge New Transparency on Drug Approval
27 Jun 2019 //
RAPS
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
17 May 2019 //
RAPS
GSK`s HIV drug wins European panel thumbs-up
26 Apr 2019 //
REUTERS
ViiV’s Dovato wins US approval PRV, empowering GSK to muscle Gilead’s HIV empire
10 Apr 2019 //
ENDPTS
Matrix Labs Generic Lamivudine Receives Approval in US
07 Mar 2019 //
FDA
Everything You Need to Know About FDA’s Priority Review Vouchers
13 Feb 2019 //
RAPS
Laurus Labs gets USFDA nod for HIV drug
09 Feb 2019 //
ECONOMIC TIMES
How a decades-old HIV drug might help treat Alzheimer`s, age-related diseases
08 Feb 2019 //
FIERCE BIOTECH
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
Indonesia seeks to reassure HIV patients over drug supplies
14 Jan 2019 //
REUTERS
JPM recap: Must-reads of the week, from FDA to IPO to M&A
12 Jan 2019 //
FIERCE PHARMA
South Africa`s Aspen launches three-in-one HIV drug
26 Nov 2018 //
ECONOMIC TIMES
Merck Announces Week 96 Data from Delstrigo for HIV-1
04 Oct 2018 //
BUSINESSWIRE
Merck’s HIV Therapy Delstrigo Meets Primary Efficacy Endpoint
04 Oct 2018 //
BUSINESSWIRE
CHMP puts 13 therapies forward for EU approval
24 Sep 2018 //
PHARMA TIMES
ViiV submits two-drug regimen for HIV in Europe
14 Sep 2018 //
PHARMA TIMES